Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR_Rx)

Amyloid. 2017 Mar;24(sup1):134-135. doi: 10.1080/13506129.2017.1280015.

Authors

Merrill D Benson¹, Elizabeth J Ackermann², Brett P Monia²

Affiliations

¹ a Department of Pathology and Laboratory Medicine , Indiana University School of Medicine , Indianapolis , IN , USA and.
² b Ionis Pharmaceuticals , Carlsbad , CA , USA.

PMID: 28434337
DOI: 10.1080/13506129.2017.1280015

No abstract available

MeSH terms

Amyloid Neuropathies / genetics
Amyloid Neuropathies, Familial / genetics*
Cardiomyopathies / genetics*
Humans
Oligonucleotides, Antisense / genetics*
Prealbumin / genetics

Substances

Oligonucleotides, Antisense
Prealbumin